知镜 Cognispect · 医学文献与研究工作台

Fusion-product control in hematologic cancers.

Zhang M, Yu L.
Trends in cancer · 2026-09-14 · PMID 42736066

文献摘要

Oncogenic fusions both drive hematologic cancers and enable precise measurable residual disease tracking, yet whether residual fusion products can be therapeutically controlled remains incompletely defined. Emerging genomic, RNA, and proteostasis strategies now frame fusion control as a layer-matched therapeutic strategy.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。